首页 › 股票 › NAMS

NAMS — NEWAMSTERDAM PHARMA COMPANY

申报持仓市值$4.74B
持有基金数(最新)326
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)210
机构持仓市值$4.75B · 141.29M 股
新建/增持/减仓/清仓51 / 73 / 53 / 23 · 更新于 2026-11-14
前五大/前十大集中度44.6% / 62.4%
机构整体持仓变动 减持 -7.5% (-10.62M 股)
机构持仓市值变动 下降 -2.2%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 210 家机构在其最新 13F 申报中持有 NAMS(NEWAMSTERDAM PHARMA COMPANY),合计申报市值 $4.75B,对应 141.29M 股。按股数计算较上季度减持 7.5%(-10.62M 股),申报市值环比下降 2.2%。持仓集中度较高:前五大持有人占申报市值的 44.6%,前十大的集中度为 62.4%。

与上一季度相比,51 家新建仓位、73 家加仓、53 家减仓、23 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

NEWAMSTERDAM PHARMA COMPANY(NAMS)的主要机构持有人包括 Frazier Life Sciences Management, L.P.、Capital World Investors、RA CAPITAL MANAGEMENT, L.P.,按 13F 申报市值在本页 326 家持有人中排名居前。

NAMS 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

持有 NAMS 的传奇投资人

我们追踪的超级投资人在各自最新 13F 申报中持有 NAMS 的名单——每位投资人按其自身最近一个季度展示。

投资人 季度 股数 金额 组合权重 变化
维京全球 Q2 2026 4.20M $142.46M 0.41% 持有
李·艾斯利 Q2 2026 3.27M $110.75M 1.00% 增持

这些投资人共同持有哪些股票?→  ·  嵌入此组件 →

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 119 44.21M $1.07B +8.9%
Q2 2026 210 141.29M $4.75B -7.5%
Q1 2026 181 145.89M $4.67B +2.9%
Q4 2025 195 139.30M $4.88B -4.9%
Q3 2025 143 142.67M $4.05B +4.3%
Q2 2025 136 136.29M $2.47B +7.9%
Q1 2025 129 125.35M $2.57B +16.9%
Q4 2024 134 108.44M $2.79B +20.6%

表内 8 个季度中,机构持股合计减少 59%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(+20.6%)。

前 25 大机构持仓人(Q3 2026) — 25 家基金

基金股数金额组合权重变化
Capital World Investors 12.88M $313.28M 0.04% 增持
Fidelity Management & Research (FMR) 12.12M $294.68M 0.01% 增持
Medicxi Ventures Management (Jersey) Ltd 历史持仓 2.18M $53.07M 41.90% 减持
Capital International Investors 1.84M $44.80M 0.01% 增持
JPMorgan Chase & Co 1.23M $29.28M 0.00% 增持
Aberdeen Group plc 1.18M $28.80M 0.04% 增持
BlackRock Inc 1.04M $25.31M 0.00% 减持
BNP Paribas Asset Management Holding S.A. 874.57K $21.27M 0.02% 增持
AMERICAN CENTURY COMPANIES INC 865.40K $21.05M 0.01% 增持
Morgan Stanley 836.58K $20.35M 0.00% 增持
Franklin Resources 866.53K $18.14M 0.00% 减持
NWI MANAGEMENT LP 历史持仓 702.00K $17.07M 0.76% 持有
TimesSquare Capital Management, LLC 573.19K $13.94M 0.23% 减持
KENNEDY CAPITAL MANAGEMENT LLC 547.63K $13.32M 0.25% 增持
Qube Research & Technologies Ltd 373.27K $9.08M 0.02% 增持
Jump Financial, LLC 357.52K $8.69M 0.08% 增持
BNY Mellon 337.98K $8.22M 0.00% 减持
Mizuho Markets Cayman LP 历史持仓 309.16K $7.52M 0.52% 增持
VICTORY CAPITAL MANAGEMENT INC 308.83K $7.51M 0.00% 增持
Atle Fund Management AB 历史持仓 303.82K $7.39M 1.98% 增持
BARCLAYS PLC 280.41K $6.82M 0.01% 增持
Affinity Asset Advisors, LLC 275.00K $6.69M 0.31% 持有
HRT FINANCIAL LP 225.08K $5.47M 0.02% 减持
Deutsche Bank AG 204.46K $4.97M 0.00% 增持
VANGUARD PORTFOLIO MANAGEMENT LLC 196.63K $4.78M 0.00% 增持

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 18.09M $613.03M 13.35% 增持
Capital World Investors 12.23M $414.49M 0.05% 增持
Capital World Investors 12.23M $414.49M 0.05% 增持
Fidelity Management & Research (FMR) 10.34M $350.41M 0.02% 增持
RA CAPITAL MANAGEMENT, L.P. 历史持仓 9.55M $323.66M 2.81% 持有
FCPM III SERVICES B.V. 历史持仓 8.49M $287.74M 38.34% 减持
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 4.26M $144.53M 1.81% 持有
Viking Global Investors 4.20M $142.46M 0.41% 持有
VIKING GLOBAL INVESTORS LP 4.20M $142.46M 0.41% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 3.81M $129.00M 7.67% 减持
Maverick Capital 历史持仓 3.27M $110.75M 1.00% 增持
MAVERICK CAPITAL LTD 历史持仓 3.27M $110.75M 1.03% 增持
Duquesne Family Office LLC 历史持仓 3.07M $104.05M 2.31% 持有
Jupiter Topco LLC 2.54M $86.01M 0.04% 新进
Medicxi Ventures Management (Jersey) Ltd 历史持仓 2.21M $74.85M 42.19% 减持
JENNISON ASSOCIATES LLC 2.10M $71.25M 0.04% 减持
Orbis Allan Gray Ltd 1.75M $59.23M 0.20% 新进
Polar Capital Holdings Plc 1.72M $58.44M 0.17% 减持
Capital International Investors 1.72M $58.41M 0.01% 增持
WESTFIELD CAPITAL MANAGEMENT CO LP 1.54M $52.07M 0.17% 减持
Castle Hook Partners LP 历史持仓 1.37M $46.46M 0.21% 增持
AMERIPRISE FINANCIAL INC 1.25M $42.48M 0.01% 增持
ALLIANCEBERNSTEIN L.P. 1.26M $40.33M 0.01% 增持
PRICE T ROWE ASSOCIATES INC /MD/ 1.17M $39.56M 0.00% 新进
JPMorgan Chase & Co 1.13M $38.37M 0.00% 增持

Q1 2026 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 16.94M $542.37M 13.96% 持有
Capital World Investors 11.11M $355.60M 0.05% 增持
Capital World Investors 11.11M $355.60M 0.05% 增持
RA CAPITAL MANAGEMENT, L.P. 历史持仓 9.55M $305.70M 3.24% 持有
FCPM III SERVICES B.V. 历史持仓 9.20M $294.46M 40.77% 持有
Fidelity Management & Research (FMR) 8.77M $280.59M 0.02% 增持
Bain Capital Life Sciences Investors, LLC 历史持仓 7.31M $233.88M 21.09% 持有
Wellington Management Group 5.12M $163.76M 0.03% 增持
WELLINGTON MANAGEMENT GROUP LLP 5.12M $163.76M 0.03% 增持
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 4.26M $136.52M 1.80% 增持
Viking Global Investors 4.20M $134.56M 0.38% 持有
VIKING GLOBAL INVESTORS LP 4.20M $134.56M 0.38% 持有
Duquesne Family Office LLC 历史持仓 3.07M $98.28M 3.10% 持有
Polar Capital Holdings Plc 2.83M $90.64M 0.40% 增持
JENNISON ASSOCIATES LLC 2.75M $88.04M 0.06% 减持
Medicxi Ventures Management (Jersey) Ltd 历史持仓 2.67M $85.60M 8.72% 减持
Janus Henderson Group 2.26M $72.25M 0.04% 减持
WESTFIELD CAPITAL MANAGEMENT CO LP 2.20M $70.52M 0.30% 新进
Maverick Capital 历史持仓 2.19M $69.99M 0.81% 增持
MAVERICK CAPITAL LTD 历史持仓 2.19M $69.99M 0.84% 增持
Goldman Sachs Group 1.95M $62.30M 0.02% 增持
Capital International Investors 1.44M $46.13M 0.01% 减持
ALLIANCEBERNSTEIN L.P. 1.20M $42.07M 0.01% 减持
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.11M $35.42M 0.06% 减持
Castle Hook Partners LP 历史持仓 1.04M $33.37M 0.14% 减持

Q4 2025 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 16.94M $594.39M 15.96% 增持
Capital World Investors 9.98M $350.24M 0.05% 增持
Capital World Investors 9.98M $350.24M 0.05% 增持
RA CAPITAL MANAGEMENT, L.P. 历史持仓 9.55M $335.02M 3.43% 减持
FCPM III SERVICES B.V. 历史持仓 9.20M $322.70M 42.30% 持有
Bain Capital Life Sciences Investors, LLC 历史持仓 7.31M $256.31M 19.63% 减持
Fidelity Management & Research (FMR) 6.41M $224.97M 0.01% 增持
Wellington Management Group 5.03M $176.56M 0.03% 增持
WELLINGTON MANAGEMENT GROUP LLP 5.03M $176.56M 0.04% 增持
Viking Global Investors 4.20M $147.46M 0.39% 减持
VIKING GLOBAL INVESTORS LP 4.20M $147.46M 0.39% 减持
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 4.16M $146.10M 2.06% 减持
JENNISON ASSOCIATES LLC 3.49M $122.40M 0.07% 减持
Duquesne Family Office LLC 历史持仓 3.07M $107.70M 2.57% 增持
Medicxi Ventures Management (Jersey) Ltd 历史持仓 2.87M $100.66M 12.06% 持有
Polar Capital Holdings Plc 2.78M $97.39M 0.45% 减持
Janus Henderson Group 2.34M $82.30M 0.04% 增持
Capital International Investors 2.06M $72.35M 0.01% 持有
Maverick Capital 历史持仓 1.89M $66.45M 0.71% 增持
MAVERICK CAPITAL LTD 历史持仓 1.89M $66.45M 0.73% 增持
Goldman Sachs Group 1.73M $60.54M 0.03% 增持
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.41M $49.34M 0.07% 减持
ALLIANCEBERNSTEIN L.P. 1.30M $45.63M 0.01% 减持
Castle Hook Partners LP 历史持仓 1.09M $38.06M 0.16% 新进
Cormorant Asset Management, LP 历史持仓 1.00M $35.08M 1.62% 减持

Q3 2025 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 16.70M $475.00M 14.23% 增持
Bain Capital Life Sciences Investors, LLC 历史持仓 10.72M $304.85M 20.23% 持有
RA CAPITAL MANAGEMENT, L.P. 历史持仓 10.14M $288.35M 3.55% 持有
Capital World Investors 9.82M $279.36M 0.04% 增持
Capital World Investors 9.82M $279.36M 0.04% 增持
FCPM III SERVICES B.V. 历史持仓 9.21M $262.00M 52.36% 减持
VIKING GLOBAL INVESTORS LP 6.48M $184.16M 0.48% 减持
Viking Global Investors 6.48M $184.16M 0.48% 减持
Fidelity Management & Research (FMR) 5.54M $157.42M 0.01% 增持
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 4.27M $121.34M 1.95% 减持
JENNISON ASSOCIATES LLC 4.20M $119.41M 0.07% 增持
WELLINGTON MANAGEMENT GROUP LLP 4.02M $114.33M 0.02% 增持
Wellington Management Group 4.02M $114.33M 0.02% 增持
Polar Capital Holdings Plc 2.91M $82.81M 0.43% 增持
Medicxi Ventures Management (Jersey) Ltd 历史持仓 2.87M $81.61M 10.96% 持有
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.58M $73.28M 0.12% 减持
Cormorant Asset Management, LP 历史持仓 2.17M $61.86M 4.27% 持有
ALLIANCEBERNSTEIN L.P. 2.14M $60.91M 0.02% 减持
Janus Henderson Group 2.12M $60.15M 0.03% 增持
Capital International Investors 2.06M $58.66M 0.01% 持有
Duquesne Family Office LLC 历史持仓 1.92M $54.71M 1.54% 增持
MAVERICK CAPITAL LTD 历史持仓 1.50M $42.80M 0.59% 减持
Maverick Capital 历史持仓 1.50M $42.80M 0.57% 减持
Morgan Stanley 1.50M $42.59M 0.00% 增持
JPMorgan Chase & Co 1.30M $37.04M 0.01% 减持

Q2 2025 — 25 家基金

基金股数金额组合权重变化
Frazier Life Sciences Management, L.P. 历史持仓 16.61M $300.75M 12.03% 增持
Bain Capital Life Sciences Investors, LLC 历史持仓 10.72M $194.12M 24.29% 持有
FCPM III SERVICES B.V. 历史持仓 10.63M $192.55M 52.16% 减持
RA CAPITAL MANAGEMENT, L.P. 历史持仓 10.14M $183.62M 3.09% 持有
Capital World Investors 8.39M $151.90M 0.02% 增持
Capital World Investors 8.39M $151.90M 0.02% 增持
VIKING GLOBAL INVESTORS LP 6.98M $126.38M 0.36% 持有
Viking Global Investors 6.98M $126.38M 0.36% 持有
DEERFIELD MANAGEMENT COMPANY, L.P. 历史持仓 5.12M $92.65M 1.81% 增持
WELLINGTON MANAGEMENT GROUP LLP 3.32M $60.18M 0.01% 减持
Wellington Management Group 3.32M $60.18M 0.01% 减持
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.01M $54.57M 0.09% 增持
JENNISON ASSOCIATES LLC 2.95M $53.35M 0.03% 减持
Medicxi Ventures Management (Jersey) Ltd 历史持仓 2.87M $51.97M 12.16% 持有
Polar Capital Holdings Plc 2.52M $45.60M 0.24% 增持
ALLIANCEBERNSTEIN L.P. 2.33M $42.22M 0.01% 增持
Cormorant Asset Management, LP 历史持仓 2.17M $39.39M 2.93% 增持
Capital International Investors 2.06M $37.35M 0.01% 持有
Janus Henderson Group 1.96M $35.59M 0.02% 减持
Fidelity Management & Research (FMR) 1.90M $34.49M 0.00% 增持
Woodline Partners LP 1.90M $34.36M 0.18% 减持
Pictet Asset Management Holding SA 1.82M $32.90M 0.03% 持有
MAVERICK CAPITAL LTD 历史持仓 1.53M $27.74M 0.42% 增持
Maverick Capital 历史持仓 1.53M $27.74M 0.42% 增持
JPMorgan Chase & Co 1.46M $26.42M 0.00% 增持

查看全部 326 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Capital World Investors 12.88M 12.23M 11.11M 9.98M 9.82M 8.39M 6.80M 1.02M — — — — — — — —
Fidelity Management & Research (FMR) 12.12M 10.34M 8.77M 6.41M 5.54M 1.90M 963.82K 212 330.41K 243.70K 243.70K — — — — —
Medicxi Ventures Management (Jersey) Ltd 2.18M 2.21M 2.67M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M 2.87M — — —
Capital International Investors 1.84M 1.72M 1.44M 2.06M 2.06M 2.06M 2.06M 2.06M — — — — — — — —
JPMorgan Chase & Co 1.23M 1.13M 884.23K 999.98K 1.30M 1.46M 991.32K 60.98K 22.35K 8.07K 4.32K — 2.62K 11.46K 22.37K 1.10K
Aberdeen Group plc 1.18M 1.10M 837.00K 729.48K 661.95K 735.03K 376.86K 179.06K 129.06K 76.00K — — — — — —
BlackRock Inc 1.04M 1.06M 886.62K 849.78K 622.51K 571.67K 497.98K 441.52K 66.67K — — — — — — —
BNP Paribas Asset Management Holding S.A. 874.57K 781.14K 957.44K 177.02K — — — — — — — — — — — —
AMERICAN CENTURY COMPANIES INC 865.40K 684.81K 519.46K 603.40K 624.28K 532.92K 528.83K 346.57K — — — — — — — —
Morgan Stanley 836.58K 575.83K 555.76K 532.80K 1.50M 637.71K 437.54K 430.10K 203.21K 24.69K 177.59K 28.54K 1.70K 808 503 —
Franklin Resources 866.53K 993.92K 770.16K 769.12K 405.82K 334.21K 255.91K — — — — — — — — —
NWI MANAGEMENT LP 702.00K 702.00K 702.00K 702.00K — — — — — — — — — — — —
TimesSquare Capital Management, LLC 573.19K 796.16K 751.99K 822.30K 837.37K 872.54K 891.09K 895.57K 255.25K 246.09K 228.62K — — — — —
KENNEDY CAPITAL MANAGEMENT LLC 547.63K 421.37K 408.49K 172.93K 146.72K 13.68K — 7.95K 14.05K 11.85K — — — — — —
Qube Research & Technologies Ltd 373.27K 47.09K — — — — — — — — — — — — — —
Jump Financial, LLC 357.52K 144.51K — — — — — 25.40K — — — — — — — —
BNY Mellon 337.98K 353.30K 378.80K 391.83K 333.00K 352.95K — — — — — — — — — —
Mizuho Markets Cayman LP 309.16K 150.54K 52.23K 47.88K — — — — — — — — — — — —
VICTORY CAPITAL MANAGEMENT INC 308.83K 172.66K 172.66K — — — — — — — — — — — — —
Atle Fund Management AB 303.82K 248.85K 94.80K 197.04K 193.62K 157.22K 107.78K 138.98K 138.98K 75.79K 22.39K — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold NAMS?

As of 2026-Q2, 210 institutional funds reported holding NAMS (NEWAMSTERDAM PHARMA COMPANY) in SEC 13F filings, with a combined reported value of $4.75B.

How many shares of NAMS do institutions own?

13F filers reported 141.29M shares of NAMS, worth $4.75B in aggregate at the end of 2026-Q2.

Is institutional ownership of NAMS rising or falling?

Share counts moved -7.5% versus the prior quarter — distribution.

Who are the top institutional holders of NAMS?

The largest 13F holders are Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Fidelity Management & Research (FMR); the top 25 are ranked at the top of this page.

Who are the major shareholders of NEWAMSTERDAM PHARMA COMPANY?

The major shareholders of NEWAMSTERDAM PHARMA COMPANY (NAMS) by reported 13F value are Frazier Life Sciences Management, L.P., Capital World Investors, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, Fidelity Management & Research (FMR), among 326 institutional holders.

Which legendary investors own NAMS?

2 of the legendary investors tracked on HoldingsHub report NAMS (NEWAMSTERDAM PHARMA COMPANY) in their latest 13F filings, led by Viking Global Investors, Lee Ainslie. Each is shown at that manager's own most recent quarter.

Do superinvestors agree on NAMS?

2 tracked superinvestors hold NAMS simultaneously — see the consensus page for the stocks they own together.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 NAMS」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/NAMS/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →